Project Title: |
DUPLEX |
Project Type: |
Clinical Trial, Enrolment ongoing Adjunct biobank: Serum, Plasma, Urine |
Disease group(s): |
Immune glomerulopathies |
Project Summary: |
A Randomized, Multicenter, Double blind, Parallel, Active control Study of the Effects of Sparsentan, a Dual Endothelin Receptor and Angiotensin Receptor Blocker, on Renal Outcomes in Patients with Primary Focal Segmental Glomerulosclerosis (FSGS) |
Lead principal investigator(s): |
Mai Rosenberg, Tartu |
Co-investigator(s): |
Kristi Veermäe, Tartu |
Project Period: |
10/2018 - 12/2023 |
Sponsors: |
Industry |
Project web page: |
https://www.fsgsduplex.com/#!/ |
ClinicalTrials.gov: |
NCT03493685 |